Ricerca
9 risultati per «drug discontinuation»
Aritmia ventricolare dovuta a tireotossicosi indotta da amiodarone: un rischio anche a distanza
La Malfa G, Barbera G, Saia GF, Cardillo M, Marchese S, Sanfilippo MF, Comparato C, corsello G — pp. 151-155
… ejection fraction. Its well-documented side effects include pulmonary and thyroid toxicity. Even after discontinuation of the drug, delayed-onset hyperthyroidism with potentially life-threatening clinical presentation may occur, a condition that highlights the need for continuous and …
Il vissuto di bambini e adolescenti con artrite idiopatica giovanile
L. Mambelli, A. Menghi, C. Lama, F. Marchetti — pp. 638-641
… S, Davì S, Consolaro A, et al.; Italian Pediatric Rheumatology Study Group. Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept. Pediatr Rheumatol Online J 2016; 14(1):68. 12. Menghi A, Lama C, …
Tacrolimus unguento
M. Lazzerini, F. Marchetti, G. Longo — pp. 102-107
… treatment of refractory facial lesion in atopic dermatitis using topical tacrolimus following corticosteroid discontinuation. Dermatology 2001;203:32-7. 19. Drake L, et al. The impact of tacrolimus ointment on health-related quality of life of adult and pediatrics patients with atopic dermatitis. …
Le patologie della tiroide nell’infanzia e nell’adolescenza
F. Chiarelli, S. Agostinelli — pp. 157-167
… M, Guitteny MA, Czernichow P, Leger J. Predictors of autoimmune hyperthyroidism relapse in children after discontinuation of antithyroid drug treatment. J Clin Endocrinol Metab 2008;93: 3817-26. 85. Cooper DS. Antithyroid drugs. N Engl J Med 2005;352:905-17. 86. Nakamura H, Noh JY, Itoh K, …
Quando l’asma è “difficile”: il ruolo dell’omalizumab
G. Vieni, L. Biserna, F. Marchetti — pp. 177-181
… 7. Molimard M, Mala L, Bourdeix I, Le Gros V. Observational study in severe asthmatic patients after discontinuation of omalizumab for good asthma control. Respir Med 2014;108(4): 571-6. 8. Corren J, Casale TB, Lanier B, Buhl R, Holgate S, Jimenez P. Safety and tolerability of omalizumab. …
Il valproato tra terapia e tossicità tubulare: viaggio all'interno della sindrome di Fanconi
Ranieri A, Pietrolati G, Perre E, Pillon R, Alberici I, Pasini A — pp. 10-15
… by the inhibition of β-oxidation and depletion of carnitine and coenzyme A. Management involved the gradual discontinuation of VPA and enteral electrolyte supplementation and led to progressive metabolic recovery. This case highlights the necessity of monitoring tubular function in paediatric …
Fibrosi cistica 2025: stato dell’arte e novità
Maschio M, Grazian F, Traunero A, Ghirardo S, Amaddeo A. — pp. 430-440
… 10.1136/ thoraxjnl-2020-215556. 85. Mayer-Hamblett N, Ratjen F, Russell R, et al.; SIMPLIFY Study Group. Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, …
Quando iniziare e quando sospendere i farmaci antiasmatici:per un razionale oltre le linee guida
G. Longo